ReShape Lifesciences Inc. (NASDAQ:RSLS) Sees Large Decrease in Short Interest

ReShape Lifesciences Inc. (NASDAQ:RSLS) saw a large decrease in short interest in the month of March. As of March 15th, there was short interest totalling 367,200 shares, a decrease of 22.1% from the February 28th total of 471,600 shares. Approximately 50.4% of the company’s shares are sold short. Based on an average daily volume of 1,090,000 shares, the days-to-cover ratio is currently 0.3 days.

ReShape Lifesciences Stock Down 9.8 %

Shares of NASDAQ:RSLS traded down $0.04 during trading hours on Monday, hitting $0.35. 570,329 shares of the company’s stock traded hands, compared to its average volume of 381,547. The business has a fifty day moving average price of $1.97 and a 200-day moving average price of $4.26. ReShape Lifesciences has a 1 year low of $0.35 and a 1 year high of $29.00.

ReShape Lifesciences Company Profile

ReShape Lifesciences Inc provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. The company's product portfolio includes Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy; Lap-Band 2.0 System, an adjustable postoperatively to increase or decrease the pressure to the band in order to optimize an individual's comfort and therapy effectiveness; and ReShape Calibration Tubes, that fits the lesser curvature of the stomach to reach the pylorus.